The PennZone

  • Home
  • Health
  • Business
  • Non-profit
  • Technology
  • Music
  • Construction
  • Sports
  • Entertainment

YPrime Launches eCOA Gen 5, a Simplified, Protocol-Tailored Solution
The PennZone/10107196

Trending...
  • Dr. Curtis Rasmussen Shares Leadership and AI Insights on Lead Empowered TV
  • The New Monaco of the South (of Italy)
  • Obey God Clothing Launches Urban Christian Apparel Line Serving All Ages
MALVERN, Pa.--(BUSINESS WIRE)--YPrime, LLC., a global leader in cloud-based eClinical solutions, announced today the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime's newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. This advanced technology enhances clinical trial efficiency, increases site satisfaction, and improves patient compliance. This release also ensures the delivery of cleaner data, streamlining the clinical trial data collection and approval process.

"With a 15-year track record as a technology leader, we are constantly innovating to help drive the digital transformation of clinical research," said YPrime Co-Founder and CEO Shawn Blackburn. "The rapid shift toward a more patient-centered approach to clinical trials is enabled by the strength of our eCOA platform."

More on The PennZone
  • Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
  • Insight Holistic Imaging Introduces In-LightN Advanced Thermography - New Personalized Wellness Scr
  • TrueNorth Wellness Services Welcomes a New CEO
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration

Tailored for today's complex clinical trials, YPrime's platform helps patients remain engaged and compliant through straightforward design. Developed to integrate intelligently with other eClinical technologies and with the ability to move between devices, YPrime offers a customized solution with the necessary control and security that ensures accurate data collection from specification to submission.

"Real-time data access enhances project control for sponsors and empowers their decision-making," said Michael Hughes, senior vice president, product development. "With superior processing power and advanced security protections, clinical development teams can be assured that they'll receive continuous, high-quality data throughout the duration of the study."

About YPrime

YPrime's cloud-based technology streamlines clinical trial data collection and management. YPrime's eCOA and interactive response technology (IRT) platforms introduce greater speed, precision, and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
  • Lineus Medical Completes UK Registration for SafeBreak® Vascular
  • Canyons & Chefs Announces Revamped Homepage
  • $140 to $145 Million in 2026 Projected and Profiled in New BD Deep Research Report on its Position in $57 Billion US Marine Industry; N Y S E: OTH
  • Really Cool Music Releases Its Fourth Single - "So Many Lost Years"
  • MGN Logistics Acquires Fast Service LLC, Fueling MyMGN Marketplace Expansion and Supercharging Expedited Coverage Nationwide
  • The Wait is Over: Salida Wine Festival Announces Triumphant 2026 Return After Seven-Year Hiatus
  • Graduates With $40K in Student Debt Are Buying Businesses Instead of Taking Entry-Level Jobs
  • Anne Seidman: Within the Lines
  • How Democrats Made Healthcare More Expensive in 2026
  • Inkdnylon Launches Bilingual Ask Inkdnylon Platform
  • JS Gallery Brings Global Voices to LA Art Show 2026 with "OFF SCRIPT" Exhibition
  • ANTOANETTA Partners With Zestacor Digital Marketing to Expand Online Presence for Handcrafted Luxury Jewelry
  • Mitchell Sipus Releases New Dance Single "Can U"
  • FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
  • The New Monaco of the South (of Italy)
  • OctoNerv Completes Functional Prototype of Electronic Breast Nipple Implant (EBNI)
  • Zivra AI Launches Real-Time Business Health and Financial Intelligence for SMEs

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 225
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 207
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
  • Children Rising Appoints Marshelle A. Wilburn as New Executive Director
  • NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
  • Bent Danholm Joins The American Dream TV as Central Florida Host
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • God's Meal Barrel Combats the Increased Community Need in 2025

Similar on PennZone

  • Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
  • Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • $140 to $145 Million in 2026 Projected and Profiled in New BD Deep Research Report on its Position in $57 Billion US Marine Industry; N Y S E: OTH
  • MGN Logistics Acquires Fast Service LLC, Fueling MyMGN Marketplace Expansion and Supercharging Expedited Coverage Nationwide
  • Graduates With $40K in Student Debt Are Buying Businesses Instead of Taking Entry-Level Jobs
  • How Democrats Made Healthcare More Expensive in 2026
  • Inkdnylon Launches Bilingual Ask Inkdnylon Platform
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us